The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development by Cong Sun, Xin-chun Chen, Yin-feng Kang, Mu-sheng Zeng

Get full text

How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection by Guo-Long Bu, Chu Xie, Yin-Feng Kang, Mu-Sheng Zeng, Cong Sun

Get full text

Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants by Yin-Feng Kang, Cong Sun, Jing Sun, Chu Xie, Zhen Zhuang, Hui-Qin Xu, Zheng Liu, Yi-Hao Liu, Sui Peng, Run-Yu Yuan, Jin-Cun Zhao, Mu-Sheng Zeng

Get full text

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants by Cong Sun, Yin-Feng Kang, Yuan-Tao Liu, Xiang-Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yi-Hao Liu, Sui Peng, Guo-Kai Feng, Zheng Liu, Mu-Sheng Zeng

Get full text

mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice by Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, Xiang‐Wei Kong, Cong Sun, Zi‐Qian Li, Dan‐Ling Dai, Hai‐Xia Sun, Yin‐Feng Kang, Guo‐Kai Feng, Qian Zhong, Mu‐Sheng Zeng

Get full text